Home » Topics » BioWorld Science

BioWorld Science
RSS

New mitomycin formulation now under FDA review

Feb. 26, 1998

IL-6 suggested to be an endogenous neuroprotective factor

Feb. 26, 1998

Cell adhesion inhibitors from Yoshitomi

Feb. 26, 1998

Agouron discloses new HIV protease inhibitors

Feb. 26, 1998

PAF antagonist protects against ischemia-reperfusion injury in heart-lung transplantation

Feb. 26, 1998

Mechanism of hypolipidemic effects of monatepil elucidated

Feb. 26, 1998

Ariflo possesses potent antiinflammatory activity, without GI side effects

Feb. 26, 1998

T-440: a new antiasthma drug candidate from Tanabe

Feb. 26, 1998

Animal study indicates efficacy of oral PAF antagonist in allergic rhinitis

Feb. 26, 1998

SSRIs appear safe for use during pregnancy

Feb. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...